Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation
Glancy Prongay Wolke & Rotter LLP today continues its investigation on behalf of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC) investors concerning the Company’s possible violations of the federal securities laws after the stock price fell 16% on July 8, 2026.
What Happened?
On July 8, 2026, reports emerged that a former Alignment executive had filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation. The lawsuit, filed by the former chief transformation officer, alleges that Alignment deliberately misclassified $8 million to $10 million in routine operating expenses (such as routine software maintenance and production support) as capital expenditures within its technology sector, thereby artificially inflating the Company's adjusted EBITDA and enabling the Company to report its "first full year of positive adjusted EBITDA as a public company".
On this news, Alignment’s stock price fell $4.02, or 16.7%, to close at $20.03 per share on July 8, 2026, thereby injuring investors.
